Loxo-Bayer cancer drug gets priority review from FDA Ruby Khatun Khatun1 Jun 2018 9:30 AM ISTLoxo Oncology and Bayer AG said the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing...
